Zoetis ZTS
NYSE ZTS
$73.04 +0.04 (+0.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026)

Zoetis' (ZTS) quarterly Other Accumulated Expenses came in at $856.0 million in Q2 2026, up 11.17% year-over-year from $770.0 million in Q2 2025, and up 13.98% quarter-over-quarter from $751.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Other Accumulated Expenses for 14 consecutive years, with $856.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 11.17% year-over-year to $856.0 million in Q2 2026; TTM through Jun 2026 was $856.0 million, a 11.17% increase from a year earlier, with the FY2025 full-year figure at $841.0 million, up 572.8% from the prior year.
  • Other Accumulated Expenses was $856.0 million for Q2 2026 at Zoetis, up from $751.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $856.0 million in Q2 2026 and troughed at $97.0 million in Q4 2022.
  • A 5-year average of $628.4 million and a median of $698.5 million in 2022 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses soared 572.8% in 2025 and decreased 2.72% in 2026, its largest moves.
  • Over 5 years, Other Accumulated Expenses stood at $97.0 million in 2022, then climbed by 5.15% to $102.0 million in 2023, then gained by 22.55% to $125.0 million in 2024, then soared by 572.8% to $841.0 million in 2025, then advanced by 1.78% to $856.0 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $856.0 million (Q2 2026), $751.0 million (Q1 2026), and $841.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 856.00 Mn
Mar 31, 2026 751.00 Mn
Dec 31, 2025 841.00 Mn
Sep 30, 2025 809.00 Mn
Jun 30, 2025 770.00 Mn
Mar 31, 2025 772.00 Mn
Dec 31, 2024 125.00 Mn
Sep 30, 2024 725.00 Mn
Jun 30, 2024 704.00 Mn
Mar 31, 2024 691.00 Mn
Dec 31, 2023 102.00 Mn
Sep 30, 2023 693.00 Mn
Jun 30, 2023 689.00 Mn
Mar 31, 2023 701.00 Mn
Dec 31, 2022 97.00 Mn
Sep 30, 2022 679.00 Mn
Jun 30, 2022 696.00 Mn
Mar 31, 2022 610.00 Mn
Dec 31, 2021 67.00 Mn
Sep 30, 2021 618.00 Mn